Gastrointestinal surgery for the morbid obese has long been an option in treatment, providing positive long-lasting results such as normal blood glucose and glycosylated hemoglobin levels and the discontinuation of diabetes-related medications. Is type 2 diabetes an operable intestinal disease? Join host Dr. Steven Edelman and his guest, chief of gastrointestinal metabolic surgery at Weill Cornell Medical College, Dr. Francesco Rubino, as they discuss the implications of metabolic surgery for type 2 patients.
Gastric Surgery for Bypassing Type 2 Diabetes
Share
SaveShare this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Gastrointestinal surgery for the morbid obese has long been an option in treatment, providing positive long-lasting results such as normal blood glucose and glycosylated hemoglobin levels and the discontinuation of diabetes-related medications. Is type 2 diabetes an operable intestinal disease? Join host Dr. Steven Edelman and his guest, chief of gastrointestinal metabolic surgery at Weill Cornell Medical College, Dr. Francesco Rubino, as they discuss the implications of metabolic surgery for type 2 patients.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?